Options in Hypersensitivity Reactions to Chemotherapeutics

作者: Mauro Pagani

DOI: 10.1007/S40521-018-0160-X

关键词:

摘要: Chemotherapeutic drugs still represent a gold standard for the treatment of neoplastic disease. They can induce hypersensitivity reactions and are third leading cause fatal drug-induced anaphylaxis in USA. This article has tried to highlight summarize most recent scientific progress concerning risk factors, pathogenesis, diagnosis, these reactions. Identification patients at high developing allows stratification guide clinical decision-making. Therefore, researches evaluated possibility perform case platinum compounds taxanes. In addition, new data now available regarding role vitro test diagnosis platins drug provocation number chemotherapeutics. However, actually, allergological work-up includes very careful anamnesis patient characteristics reaction, whereas skin tests useful only few classes chemotherapy, namely salts probably Premedication, desensitization and, some cases, able prevent majority reactions, permitting administration effective therapy. Clearly, more studies needed better understand, diagnose, treat, To reach this aim, multidisciplinar approach cancer with potential allergies is needed.

参考文章(96)
Patrizia Bonadonna, Mauro Pagani, Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin. Anticancer Research. ,vol. 34, pp. 537- 540 ,(2014)
Brian A. Baldo, Mauro Pagani, Adverse events to nontargeted and targeted chemotherapeutic agents: emphasis on hypersensitivity responses. Immunology and Allergy Clinics of North America. ,vol. 34, pp. 565- 596 ,(2014) , 10.1016/J.IAC.2014.04.003
Joana Caiado, Mariana Castells, Presentation and Diagnosis of Hypersensitivity to Platinum Drugs. Current Allergy and Asthma Reports. ,vol. 15, pp. 15- 15 ,(2015) , 10.1007/S11882-015-0515-3
Suna He, Zheng Cui, Xueqing Wang, Hua Zhang, Wenbing Dai, Qiang Zhang, Cremophor-free intravenous self-microemulsions for teniposide: Safety, antitumor activity in vitro and in vivo International Journal of Pharmaceutics. ,vol. 495, pp. 144- 153 ,(2015) , 10.1016/J.IJPHARM.2015.08.005
Loretta VanCamp, Barnett Rosenberg, The Successful Regression of Large Solid Sarcoma 180 Tumors by Platinum Compounds Cancer Research. ,vol. 30, pp. 1799- 1802 ,(1970)
Maurie Markman, Alexander Kennedy, Kenneth Webster, Paul Elson, Gertrude Peterson, Barbara Kulp, Jerome Belinson, Clinical Features of Hypersensitivity Reactions to Carboplatin Journal of Clinical Oncology. ,vol. 17, pp. 1141- 1141 ,(1999) , 10.1200/JCO.1999.17.4.1141
M M Hudson, H J Weinstein, S S Donaldson, C Greenwald, L Kun, N J Tarbell, W A Humphrey, C Rupp, N M Marina, J Wilimas, Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. Journal of Clinical Oncology. ,vol. 11, pp. 1080- 1084 ,(1993) , 10.1200/JCO.1993.11.6.1080
Maurie Markman, Alexander Kennedy, Kenneth Webster, Barbara Kulp, Gertrude Peterson, Jerome Belinson, Paclitaxel-Associated Hypersensitivity Reactions: Experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer Center Journal of Clinical Oncology. ,vol. 18, pp. 102- 105 ,(2000) , 10.1200/JCO.2000.18.1.102
B L Asselin, J C Whitin, D J Coppola, I P Rupp, S E Sallan, H J Cohen, Comparative pharmacokinetic studies of three asparaginase preparations. Journal of Clinical Oncology. ,vol. 11, pp. 1780- 1786 ,(1993) , 10.1200/JCO.1993.11.9.1780